Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New vaccine protects infant monkeys from diarrhea and promotes growth

A vaccine originally developed to prevent bacteria-caused diarrhea has now also been found to help infant nonhuman primates grow faster, according to a new study published in Nature Communications.

6 Jul 2023

Aneuploidy could function as a therapeutic target for cancer

Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming tumors.

6 Jul 2023

"Médecins solidaires" and dRural: Two innovative projects to fight medical deserts

In France, 9 million people struggle to access general practitioners. Worldwide, half of the population has fewer primary care resources than their urban counterparts.

6 Jul 2023

Wastewater monitoring can be an effective tool for global disease surveillance

Wastewater monitoring could act as an early warning system to help countries better prepare for future pandemics, according to a new study.

6 Jul 2023

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

Study aimed to compile Kiwifruit allergy recognition patterns to enhance patient management and clinical practice.

6 Jul 2023

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

CDC to reduce funding for states’ child vaccination programs

The Centers for Disease Control and Prevention is reducing funding to states for child vaccination programs, according to an agency email obtained by KFF Health News.

5 Jul 2023

Danish researchers solve puzzle of how hepatitis C virus evades immune system

With a new method for examining virus samples researchers from the University of Copenhagen have solved an old riddle about how Hepatitis C virus avoids the human body's immune defenses.

5 Jul 2023

Harnessing the power of AI: deep-learning model forecasts 30-day mortality in pneumonia cases

Researchers developed a deep learning (DL) model to estimate 30.0-day mortality risk for pneumonia.

5 Jul 2023

Climate change's impact on health and healthcare in Northern NSW: Urgent action needed

A systematic review published in the International Journal of Environmental Research and Public Health describes the impact of climate change on health and health services in Northern New South Wales, Australia. This region is considered a “hotspot” for floods and bushfires in Australia.

4 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

Global efforts to reduce infectious diseases must include older children and adolescents

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.

4 Jul 2023

New regulatory system discovered in malaria parasite

Gene expression within the apicoplast, an organelle in the malaria parasite Plasmodium falciparum, is regulated by melatonin (the circadian signaling hormone) in host blood, and intrinsic parasite cues, via a factor called ApSigma, as identified by a recent study aided by Tokyo Tech's World Research Hub Initiative.

3 Jul 2023

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

3 Jul 2023

Bluetongue virus carriers active in winter, study finds

Bluetongue virus, an incurable cattle and sheep-killing disease, is spread by tiny flies once thought to disappear in winter. New research demonstrates that though they are harder to find when it's cold, they remain active.

3 Jul 2023

Multiple drug targets for the treatment of influenza identified using AI program

Poolbeg Pharma, a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, announces a significant breakthrough in its world first influenza Artificial Intelligence ('AI') Programme with CytoReason.

1 Jul 2023

Deep learning model could help identify high-risk patients with community-acquired pneumonia

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), a deep learning-based model using initial chest radiographs predicted 30-day mortality in patients with community-acquired pneumonia (CAP), improving upon the performance of an established risk prediction tool (i.e., CURB-65 score).

30 Jun 2023